OrbiMed Advisors »

Myriad Genetics shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Myriad Genetics (MYGN) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Myriad Genetics

Tip: Access up to 7 years of quarterly data

All positions including Myriad Genetics held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Myriad Genetics by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2013-03-31 $4.3M 170k 25.41

More positions owned by OrbiMed Advisors

Edgewise Therapeutics (EWTX)
Enliven Therapeutics (ELVN)
Avita Therapeutics (RCEL)
Mdxhealth Sa Shs New Call Option (MDXH)
Eli Lilly & Co. (LLY)
Sinovac Biotech SHS
Boston Scientific Corporation (BSX)
Sionna Therapeutics (SION)
Astrazeneca Ord (AZN)
Myriad Genetics (Principal) (MYGN)
Mbx Biosciences (MBX)
Corvus Pharmaceuticals (CRVS)
Argenx Se Sponsored Adr (ARGX)
Edwards Lifesciences (EW)
Intuitive Surgical Com New (ISRG)

View all positions for OrbiMed Advisors

Top funds holding Myriad Genetics

OrbiMed Advisors
BlackRock
Vanguard Group
Millennium Management
State Street Corporation
Glenview Captal Management
D. E. Shaw & Co
Vanguard Capital Management
Morgan Stanley
Vanguard Portfolio Management
Goldman Sachs Group
Geode Capital Management
Acadian Asset Management
Jacobs Levy Equity Management
Federated Investors

View all funds holding Myriad Genetics